Literature DB >> 29032460

The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.

Alireza Shah-Hosseini1, Mohammad Jafari1,2, Asadollah Mohammadi1,3, Roozbeh Sanaei1, Seyed Moayed Alavian4, Amin Doosti-Irani5, Mehrnoush Nooradeh Keykavousi6, Nader Tajik7.   

Abstract

Killer cell immunoglobulin like receptors (KIRs) have a principal role in regulating the effector functions of NK cells, particularly in viral infections. The major ligands for KIRs are human leukocyte antigen (HLA) class I molecules. The aim of this study is to investigate the possible association of KIR genes, their known HLA ligands and compound KIR-HLA genotypes with hepatitis B virus (HBV) infection. Our study group consisted of 202 Iranian HBV-infected patients (52 spontaneously recovered, 50 asymptomatic carriers, 50 chronic sufferers and 50with liver cirrhosis) and 100 ethnic-matched healthy control subjects. KIR and HLA genotyping was performed by a polymerase chain reaction-sequence-specific primer (PCR-SSP). The frequencies of the KIR2DL5A, KIR2DS1, and KIR3DS1 genes were significantly elevated in recovered individuals when compared with both control and patient groups. Also, KIR2DL5, and KIR3DP1 full were escalated in recovered individuals in comparison with patient groups. In addition, HLA-Bw4 ligand and HLA-A Bw4 were highly frequent in recovered individuals compared with healthy controls. Furthermore, the KIR3DS1 + HLA-Bw4, KIR3DS1 + HLA-Bw4 Iso80 , and KIR3DS1 + HLA-A Bw4 genotypes were significantly more common in recovered individuals than both healthy control and patient groups. Interestingly, AA genotype had less frequency and Bx had higher frequency in recovered individuals compared with both healthy control and patient groups. Our findings suggest a potential impact of the NK cells' activating phenotype that leads to the HBV clearance in infected individuals.

Entities:  

Keywords:  Genotyping; HBV infection; HLA ligand genes; KIR genes; NK cells

Mesh:

Substances:

Year:  2017        PMID: 29032460     DOI: 10.1007/s00430-017-0522-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  40 in total

1.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

Authors:  Eric T T L Tjwa; Gertine W van Oord; Joost P Hegmans; Harry L A Janssen; Andrea M Woltman
Journal:  J Hepatol       Date:  2010-09-06       Impact factor: 25.083

Review 2.  Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.

Authors:  Kerry S Campbell; Amanda K Purdy
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

3.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

4.  Distribution of KIR genes in the Iranian population.

Authors:  N Tajik; F Shahsavar; T Mousavi; M F Radjabzadeh
Journal:  Tissue Antigens       Date:  2009-04-21

Review 5.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

6.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

Review 7.  KIR/HLA interactions and pathogen immunity.

Authors:  Khaleel M Jamil; Salim I Khakoo
Journal:  J Biomed Biotechnol       Date:  2011-05-19

8.  The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

Authors:  D Pende; R Biassoni; C Cantoni; S Verdiani; M Falco; C di Donato; L Accame; C Bottino; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 9.  Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.

Authors:  Ejuan Zhang; Mengji Lu
Journal:  Med Microbiol Immunol       Date:  2014-12-31       Impact factor: 3.402

10.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  2 in total

1.  HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells.

Authors:  Pia Fittje; Angelique Hœlzemer; Wilfredo F Garcia-Beltran; Sarah Vollmers; Annika Niehrs; Kerri Hagemann; Glòria Martrus; Christian Körner; Frank Kirchhoff; Daniel Sauter; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2022-06-24       Impact factor: 7.464

2.  Molecular epidemiology; New but impressive.

Authors:  Maryam Honardoost; Azam Rajabpour; Ladan Vakili
Journal:  Med J Islam Repub Iran       Date:  2018-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.